Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...
Jacob Berlin, PhD, CEO of Terray Therapeutics, explains that the critical element to “get right” for a preclinical drug discovery campaign is identifying molecules that rank best among the candidate ...
A computational tool has accurately predicted a drug combination that inhibited triple-negative breast cancer in in vitro experiments. Researchers at the Icahn School of Medicine at Mount Sinai (NY, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results